The Dana-Farber Cancer Institute, affiliated with Harvard Medical School, is one of the leading cancer treatment and research centers in the world. It is a global reference in the field, due to the adoption of the best clinical practices and the constant incorporation of technologies that help combat cancer.
One of the characteristics of the Dana-Farber’s clinical staff is ultra-specialization, which is not limited to the classic division into specialties, such as breast, lung, or hematology: there are oncologists who work on different types of breast cancer, for example, ensuring significant gains in clinical practice.
Oncoclínicas&Co and the Dana-Farber Cancer Institute
To ensure that its patients and clinical staff have access to the latest in cancer treatment, Oncoclínicas&Co maintains an exclusive partnership with the Dana-Farber Cancer Institute in Brazil. From the initial objective of exchanging experiences between the two centers focusing on clinical education and training programs, we have advanced in other directions, including professionals from other areas and joint research.
Every year, Oncoclínicas&Co sends oncologists from various specialties for a training period at the Dana-Farber Cancer Institute in Boston, located in Boston (USA). Virtual forums for the discussion of complex cases among teams also help in the best choice of clinical conduct for each patient and in the exchange of experience among oncologists.
The partnership now also includes professionals such as nurses and pharmacists. The idea is to better qualify the teams that support the patient within the concept of multidisciplinary care that guides the Group’s actions in the constant search for best practices. Another evolution of the partnership involves research in oncology, especially in lung and breast areas.
The joint work and proximity between Oncoclínicas&Co and the Dana-Farber Cancer Institute ensure oncologists and other professionals constant updating on what is developing in new therapies, and, to the patient, access to the best available treatment.
Reference: https://www.dana-farber.org/
